Halozyme
HALO
460 hedge funds and large institutions have $6.4B invested in Halozyme in 2024 Q2 according to their latest regulatory filings, with 79 funds opening new positions, 161 increasing their positions, 160 reducing their positions, and 30 closing their positions.
451% more call options, than puts
Call options by funds: $19.7M | Put options by funds: $3.58M
175% more funds holding in top 10
Funds holding in top 10: 4 → 11 (+7)
163% more first-time investments, than exits
New positions opened: 79 | Existing positions closed: 30
27% more capital invested
Capital invested by funds: $5.03B → $6.4B (+$1.37B)
11% more funds holding
Funds holding: 414 → 460 (+46)
1% more repeat investments, than reductions
Existing positions increased: 161 | Existing positions reduced: 160
1.31% less ownership
Funds ownership: 97.39% → 96.08% (-1.3%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FCM
Frontier Capital Management
Boston,
Massachusetts
|
+$26.4M |
| 2 |
BTW
Boston Trust Walden
Boston,
Massachusetts
|
+$19.4M |
| 3 |
Millennium Management
New York
|
+$12.8M |
| 4 |
Handelsbanken Fonder
Stockholm,
Sweden
|
+$12.5M |
| 5 |
UBS AM
Chicago,
Illinois
|
+$11.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Thrivent Financial for Lutherans
Minneapolis,
Minnesota
|
-$33.9M |
| 2 |
State Street
Boston,
Massachusetts
|
-$29.5M |
| 3 |
BlackRock
New York
|
-$27.3M |
| 4 |
Lazard Asset Management
New York
|
-$15.5M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
-$14.8M |
HALO Hedge Fund Activity: Q2 2024 in Review
460 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Halozyme (HALO) for Q2 2024, worth a combined $6.4B — up 27% from $5.03B a quarter earlier.
Buyers outnumbered sellers: 79 funds opened new HALO positions and 30 closed out — a net gain of 49 holders — while 161 added to existing stakes and 160 trimmed.
The largest buyer was Frontier Capital Management, adding an estimated $26.4M. The largest seller was Thrivent Financial for Lutherans, cutting an estimated $33.9M.
- 460 institutional investors held Halozyme (HALO) as of Q2 2024, up from 414 in Q1 2024.
- Funds reported $6.4B of Halozyme stock for Q2 2024, up 27% quarter-over-quarter.
- 79 funds opened new Halozyme positions in Q2 2024 and 30 closed out, a net change of +49 holders.
- The largest Halozyme buyer in Q2 2024 was Frontier Capital Management, an estimated $26.4M added.
- The largest Halozyme seller in Q2 2024 was Thrivent Financial for Lutherans, an estimated $33.9M sold.
Based on aggregated 13F filings for Q2 2024.